gt90001
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2021 (NCT05178043)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04984668 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2021 | Alphamab Co., Ltd., Suzhou Kintor Pharmaceutical Inc, |
| NCT05178043 | Phase 2 | Aug 1, 2021 | Suzhou Kintor Pharmaceutical Inc, |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Kintor Pharmaceutical Inc, | For profit | 2 | 2 | 1 | 2021 |
| Alphamab Co., Ltd. | For profit | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1